1. Home
  2. ONDS vs TFX Comparison

ONDS vs TFX Comparison

Compare ONDS & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ondas Holdings Inc.

ONDS

Ondas Holdings Inc.

HOLD

Current Price

$10.42

Market Cap

4.8B

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$122.48

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONDS
TFX
Founded
2014
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
ONDS
TFX
Price
$10.42
$122.48
Analyst Decision
Strong Buy
Hold
Analyst Count
5
10
Target Price
$19.00
$140.22
AVG Volume (30 Days)
68.3M
975.6K
Earning Date
04-14-2026
05-27-2026
Dividend Yield
N/A
1.11%
EPS Growth
30.68
N/A
EPS
N/A
N/A
Revenue
$7,192,694.00
$1,992,713,000.00
Revenue This Year
$582.00
$9.54
Revenue Next Year
$267.80
$10.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$100.18
52 Week High
$15.28
$143.32

Technical Indicators

Market Signals
Indicator
ONDS
TFX
Relative Strength Index (RSI) 49.67 68.41
Support Level $5.26 $117.58
Resistance Level $11.64 $126.38
Average True Range (ATR) 1.00 4.83
MACD 0.05 1.92
Stochastic Oscillator 45.33 94.96

Price Performance

Historical Comparison
ONDS
TFX

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: